-
- H Guy Richard
- Department of Pharmacy & Pharmacology, University of Bath, UK
この論文をさがす
抄録
Transdermal drug delivery represents a validated technology which is contributing significantly to global pharmaceutical care. Over the last 40 years, impressive growth in this field has been observed with many commercial successes;indeed, very recently, a new chemical entity has been developed and approved for transdermal administration without first passing via an injectable or oral dosage form. The progress achieved has been catalyzed by the clearer understanding of skin barrier function, and of the physicochemical, pharmacokinetic and physiological factors which determine the feasibility of transdermal administration. Research into novel, non-invasive approaches to facilitate and control drug transport across the skin is intensive, with certain technologies, such as iontophoresis, now achieving true maturity. Advances in the field have also allowed the "local", subcutaneous delivery of drugs (for example, to underlying muscle and other tissues) to be improved and the opening of new markets in this lucrative area may be envisaged.
収録刊行物
-
- Drug Delivery System
-
Drug Delivery System 22 (4), 442-449, 2007
日本DDS学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204641680512
-
- NII論文ID
- 10019731372
-
- NII書誌ID
- AN10084591
-
- COI
- 1:CAS:528:DC%2BD2sXhtVCqs7fJ
-
- ISSN
- 18812732
- 09135006
-
- NDL書誌ID
- 8913138
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可